These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2119043)

  • 1. The effects of thromboxane A2 inhibitors (OKY-046 and ONO-3708) and leukotriene inhibitors (AA-861 and LY-171883) on CCl4-induced chronic liver injury in mice.
    Shimazawa T; Nagai H; Koda A; Kasahara M
    Prostaglandins Leukot Essent Fatty Acids; 1990 May; 40(1):67-71. PubMed ID: 2119043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of thromboxane A2 [TxA2] in liver injury in mice.
    Nagai H; Shimazawa T; Yakuo I; Aoki M; Koda A; Kasahara M
    Prostaglandins; 1989 Oct; 38(4):439-46. PubMed ID: 2813811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of OKY-046 and ONO-3708 on liver injury in mice.
    Nagai H; Aoki M; Shimazawa T; Yakuo I; Koda A; Kasahara M
    Jpn J Pharmacol; 1989 Oct; 51(2):191-7. PubMed ID: 2512404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of peptide-leukotrienes in liver injury in mice.
    Nagai H; Shimazawa T; Yakuo I; Aoki M; Koda A; Kasahara M
    Inflammation; 1989 Dec; 13(6):673-80. PubMed ID: 2575600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of selective inhibitor of thromboxane synthetase (OKY-046) and thromboxane antagonist (ONO-3708) on ischemia-induced mitochondrial dysfunction in canine heart.
    Ito T; Ito Y; Torii T; Hieda N; Toki Y; Miyazaki Y; Hashimoto H; Ogawa K; Satake T
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():392-6. PubMed ID: 2959085
    [No Abstract]   [Full Text] [Related]  

  • 6. Protective effects of a thromboxane synthetase inhibitor, a thromboxane antagonist, a lipoxygenase inhibitor and a leukotriene C4, D4 antagonist on myocardial injury caused by acute myocardial infarction in the canine heart.
    Ito T; Toki Y; Hieda N; Okumura K; Hashimoto H; Ogawa K; Satake T
    Jpn Circ J; 1989 Sep; 53(9):1115-21. PubMed ID: 2513429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachidonic acid metabolites in carbon tetrachloride-induced liver injury.
    Kawada N; Mizoguchi Y; Kobayashi K; Yamamoto S; Morisawa S
    Gastroenterol Jpn; 1990 Jun; 25(3):363-8. PubMed ID: 2113499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thromboxane A2 activity during warm ischemia of the liver.
    Shirabe K; Kin S; Shinagawa Y; Chen S; Payne WD; Sugimachi K
    J Surg Res; 1996 Feb; 61(1):103-7. PubMed ID: 8769950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new thromboxane A2-antagonist (ONO-3708) and a new leukotriene-antagonist (ONO-1078) on thromboxane A2 analogue-, leukotriene C4-, and D4-induced regional myocardial blood flow reduction.
    Torii T; Toki Y; Hieda N; Ito Y; Okumura K; Hashimoto H; Ito T; Ogawa K; Satake T
    Heart Vessels; 1988; 4(2):104-11. PubMed ID: 3253270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of thromboxane A2 (TxA2) in allergic cutaneous reactions and the effect of (E)-3-[p-(1H-imidazol-1-ylmethyl) phenyl]-2-propenoic acid hydrochloride (OKY-046), a TxA2 synthetase inhibitor.
    Nagai H; Yakuo I; Nakatomi I; Inagaki N; Koda A
    Prostaglandins Leukot Essent Fatty Acids; 1989 Mar; 35(3):125-30. PubMed ID: 2710796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects.
    Fujimura M; Sasaki F; Nakatsumi Y; Takahashi Y; Hifumi S; Taga K; Mifune J; Tanaka T; Matsuda T
    Thorax; 1986 Dec; 41(12):955-9. PubMed ID: 3590057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological modulation of antigen-induced airway hyperresponsiveness by thromboxane A2 inhibitors in guinea pigs.
    Nagai H; Tsuji F; Goto S; Koda A
    Biol Pharm Bull; 1993 Nov; 16(11):1099-103. PubMed ID: 8312863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of three novel thromboxane A2 receptor antagonists (S-1452, AA-2414 and ONO-3708) on the increase in pulmonary pressure caused by Forssman anaphylaxis in guinea-pigs.
    Nagai H; Kumimoto M; Yoshitake K; Iwama T; Arimura A; Koda A
    Prostaglandins Leukot Essent Fatty Acids; 1992 Mar; 45(3):233-8. PubMed ID: 1534171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs.
    Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory action of OKY-O46.HCl, a specific TXA2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness of guinea pigs: role of TXA2 in development of PAF-induced nonspecific airway hyperresponsiveness.
    Takehana Y; Hamano S; Kikuchi S; Komatsu H; Okegawa T; Ikeda S
    Jpn J Pharmacol; 1990 Apr; 52(4):621-30. PubMed ID: 2160552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of thromboxane A2 synthetase inhibitor (OKY-046) on leukotriene C4-induced airway hyperresponsiveness in guinea pigs].
    Tsukagoshi H; Yodonawa S; Kurosawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jun; 31(6):707-11. PubMed ID: 8345703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ONO-3122 (an enhancer of PGH2 production) and OKY-1581 (an inhibitor of TXA2 production) on the vasopressin-induced water flow in the toad bladder.
    Marumo F
    Pharmacology; 1985; 31(1):34-9. PubMed ID: 3927326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046.
    Hatziantoniou C; Papanikolaou N
    Experientia; 1986 Jun; 42(6):613-5. PubMed ID: 3522267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
    Morimoto K; Ikata T; Tounai T
    Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.